Cascade Pharmaceuticals, Inc

Building 10, No.860, Xinyang Road, Lin-Gang Special Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, China

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

53.9%

Phase 2

38.5%

Phase 3

7.7%

Trial Status Distribution

Active, not recruiting

30.8%

Completed

53.9%

Recruiting

15.4%

Clinical Trials

Trials sponsored by this organization (13)

A Study of CS060380 Tablets in Patients With MASH and Obesity

Phase 2

Active, not recruiting

interventional

Apr 2026130 participants

Drug Interaction and Food Effect Study of CS0159

Phase 1

Completed

interventional

Mar 202632 participants

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

Phase 3

Recruiting

interventional

Dec 2025135 participants

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

Phase 2

Recruiting

interventional

Sep 2025120 participants

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects

Phase 1

Active, not recruiting

interventional

Apr 202580 participants

A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Phase 1

Completed

interventional

Mar 202524 participants

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects

Phase 1

Completed

interventional

Sep 2024104 participants

Study of [14C]CS0159 in China Healthy Subjects

Phase 1

Completed

interventional

Oct 20236 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations